普健生物(武汉)科技有限公司
首页 产品目录 产品目录(简版) 公司动态 企业认证 企业体检 公司相册 联系我们

武汉艾必赛生物有限公司推荐Anti-Human CD3 Antibody (SP34),精品抗体

发布人:普健生物(武汉)科技有限公司

发布日期:2026/3/19 17:15:30

链接:https://www.abinscience.cn/product/40/4316.htm
名称:Anti-Human CD3 Antibody (SP34)

Accession号:P07766

货号:HY057507

种属反应性:Human

宿主:Mouse

形式:Liquid

纯度:>95% as determined by SDS-PAGE.

克隆性:Monoclonal

同种型:IgG2a, kappa

应用:FCM

靶点:T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

用途范围:仅用于科研

储存:Use  a manual defrost freezer and avoid repeated freeze-thaw cycles. Store  at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C  long term.

 

产品介绍:Anti-Human  CD3 Antibody (SP34) (HY057507) 是武汉艾必赛生物技术有限公司 (abinScience)  推出的一款高特异性小鼠源单克隆抗体。该抗体靶向人T细胞表面抗原T3/Leu-4的ε链 (T3E/CD3e),此靶点是T细胞受体 (TCR)  复合物的关键组分,在T细胞的抗原识别与活化信号转导中发挥核心作用。本品克隆号为SP34,同种型为IgG2a, kappa,通过Protein  A/G方法纯化,纯度经SDS-PAGE检测高于95%。该抗体经严格验证适用于流式细胞术  (FCM),可特异性检测人源样本中CD3ε蛋白的表达。其经典的单克隆抗体结构确保了高度的特异性和批次间的一致性,是进行T细胞免疫分型、免疫功能研究及相关疾病机制探索的可靠工具试剂。

 

产品购买联系方式:027-87433958/17302791434

邮箱:info@abinscience.com

图片.png

 

参考文献:

 

Cholesterol inhibits TCR signaling by directly restricting TCR-CD3 core tunnel motility. PMID: 35271814

 

Structural basis of assembly of the human T cell receptor-CD3 complex. PMID: 31461748

 

CD3(+)CD20(+) T cells and their roles in human diseases. PMID: 30639700

 

CD3 delta immunodeficiency. PMID: 15640687

 

Optimizing  efficacy and safety of T cell bispecific antibodies: the  interdependence of CD3 and tumor antigen binder affinities in FOLR1 and  CEACAM5 2 + 1 TCBs. PMID: 41196029

 

Current Knowledge about CD3(+)CD20(+) T Cells in Patients with Multiple Sclerosis. PMID: 39201672

 

Engineered CD3 antibodies for immunosuppression. PMID: 12930354

 

CD3-specific antibody-induced active tolerance: from bench to bedside. PMID: 12563296

 

Characterization of CD3+/CD20+ canine large-cell lymphoma. PMID: 37837199

 

Back on the scene: Advances and challenges in CD3-related drugs in tumor therapy. PMID: 35489674

 

Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. PMID: 7557948

 

Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. PMID: 36991534

 

Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection. PMID: 8861551

 

CD3 zeta defects in systemic lupus erythematosus. PMID: 22460144

 

Combining  CD3/GD2 bispecific T cell engager with human Vgamma9Vdelta2 T cells  facilitates neuroblastoma cell targeting and killing in vitro. PMID:  40489497

 

Internalization and intracellular fate of TCR-CD3 complexes. PMID: 11100805

 

[CD3 subunit deficiencies]. PMID: 11212834

 

Key  links in the physiological regulation of the immune system and disease  induction: T cell receptor -CD3 complex. PMID: 39029632

 

Rigid crosslinking of the CD3 complex leads to superior T cell stimulation. PMID: 39281668

 

Atomic-resolution view of complete TCR-CD3 revealed. PMID: 31907795

 

CD3+  Tumor-Infiltrating Lymphocytes in Breast Carcinoma: Their Prognostic  Role and Association With Clinical Parameters. PMID: 39791074

 

The TCR/CD3 complex: molecular interactions in a changing structure. PMID: 12371622

 

The  novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP,  redirects T cell cytotoxicity toward antibody-bound target cells. PMID:  39763374

 

CD3(+)CD8(+)CD28(-) T Lymphocytes in Patients with Lupus Nephritis. PMID: 27446964

 

Changing roles of CD3 + CD8 low T cells in combating HIV-1 infection. PMID: 36580634

 

T-cell-receptor isoforms. PMID: 1428396

 

Expansion of mixed immune cells using CD3/CD161 co-stimulation for the treatment of cancer. PMID: 37100864

 

CD3+ T cell depletion paradoxically worsens intracerebral hemorrhage through blood-brain barrier disruption. PMID: 40985817

 

Can we define CD3(+)CD56(+) cells as NKT cells with impunity? PMID: 33662591

 

Composition of TCR-CD3 complex in human intestinal intraepithelial lymphocytes: lack of Fc epsilon RI gamma chain. PMID: 7495730

 

T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. PMID: 9368773

 

Moniezia benedeni drives CD3(+) T cells residence in the sheep intestinal mucosal effector sites. PMID: 38371601

 

Use of CD3 antibodies in transplantation and autoimmune diseases. PMID: 7998111

 

Proinflammatory CD20(+)CD3(+) T cells as a potential driver of macrophage reprogramming in rheumatoid arthritis. PMID: 41411762

 

The CD3 epsilon subunit of the TCR contains endocytosis signals. PMID: 10384095

 

Human  CD3(+)CD56(+)NKT-like cells express a range of complement receptors and  C3 activation has negative effects on these cell activity and effector  function. PMID: 34134908

 

Implicit Flow Cytometric Diagnosis of Classic Hodgkin Lymphoma Using CD3(+)CD4(+)CD26(-) T-Cells. PMID: 39235202

 

CD3 zeta and eta chains are produced by alternative splicing from a common gene. PMID: 2150596

 

The  phenotype of CD3-CD56(bright) and CD3-CD56(dim) natural killer cells in  systemic lupus erythematosus patients and its relation to disease  activity. PMID: 36186836

 

 

详情请咨询 abinScience 亚洲区官方子公司 —— 武汉艾必赛生物技术有限公司

官方网址:【中文】https://www.abinscience.cn

       【英文】https://www.abinscience.com




武汉艾必赛生物技术有限公司成立于 2023 年,是 abinScience 在亚洲地区设立的官方全资子公司,全面负责 abinScience 品牌在亚太市场的科研试剂推广、销售及技术支持工作。

依托严格的产品研发体系和国际化的质量管理标准,武汉艾必赛与 AtaGenix、ProteoGenix 等知名品牌保持长期战略合作,现已构建起涵盖抗体、重组蛋白、工具酶、试剂盒、实验耗材在内的多品类供应体系,面向区域内科研机构、高校实验室与生物医药企业,提供稳定、高效、可信赖的产品与服务。

核心业务覆盖:
✅ 抗体产品(单抗、多抗、重组抗体等)
✅ 蛋白与多肽试剂(标签蛋白、功能蛋白等)
✅ 分子与细胞实验相关耗材
✅ 定制化研发服务(蛋白表达、抗体定制、亲和力成熟等)
✅ 科研供应链整合与项目配套支持

武汉艾必赛始终秉持“Empowering Bioscience Discovery”的理念,为亚太地区的生命科学研究持续注入高质量动能。

 

新闻图片1

 

相关新闻资讯

OMIP-023:10色13抗体panel实现人外周血白细胞深度表型分析

2026/03/23

方案设计背景与研究目的OMIP-023旨在通过单管10色流式细胞术,在一次检测中系统性解析人外周血白细胞主要亚群及其活化状态。该方案针对传统多管检测在样本消耗、检测效率及信息整合方面的局限进行了系统优化,适用于需要在有限样本条件下获取全面免疫信息的科研与临床研究场景。 多参数复用的面板构建思路OMIP-023的核心设计在于通过荧光通道复用提升单位实验的信息密度,将CD8、CD14和CD19共标于F

武汉艾必赛生物有限公司推荐Anti-Human CD3 Antibody (SP34),精品抗体

2026/03/19

链接:https://www.abinscience.cn/product/40/4316.htm名称:Anti-Human CD3 Antibody (SP34)Accession号:P07766货号:HY057507种属反应性:Human宿主:Mouse形式:Liquid纯度:>95% as determined by SDS-PAGE.克隆性:Monoclonal同种型:IgG2a, kap

2026-2027流感科研靶标更新!WHO公布北半球流感季疫苗组分

2026/03/19

2026年2月27日,世界卫生组织(WHO)正式发布2026-2027年北半球流感季流感疫苗病毒成分推荐建议。该建议基于WHO全球流感监测和应对系统(GISRS)全年监测数据分析最终确定,既是全球流感疫苗研发、生产与监管的核心指导性文件,也为北半球流感相关科研工作划定了核心靶标。 一、2025-2026流感季全球流行态势核心特征本次疫苗组分更新,核心依据为2025-2026流感季全球流感流行监测数